List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 918 studies with search of: "Paraproteinemias"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Conditions: Demyelinating Diseases;   Paraproteinemias
Intervention: Drug: intravenous immunoglobulin (IVIg)
2 Terminated Study of Epratuzumab (hLL2) in Patients With Waldenstrom's Macroglobulinemia
Condition: Waldenstrom Macroglobulinemia
Intervention: Drug: Epratuzumab (hLL2- anti-CD22 humanized antibody)
3 Completed Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: SGN-40 (anti-huCD40 mAb)
4 Recruiting Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: SGN-40;   Drug: lenalidomide;   Drug: dexamethasone
5 Recruiting Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant
Conditions: Myelodysplastic and Myeloproliferative Disorders;   Acute Myelogenous Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myelogenous Leukemia;   Multiple Myeloma;   Plasma Cell Dyscrasia;   Lymphoproliferative Disorders;   Hematologic Diseases
Interventions: Drug: Campath;   Drug: Busulfan;   Drug: Fludarabine;   Procedure: Hematopoietic stem cell infusion;   Drug: FK-506
6 Completed Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H
Conditions: Myelodysplastic Disorders;   Leukemia;   Multiple Myeloma;   Plasma Cell Dyscrasia;   Lymphoproliferative Disorders
Interventions: Drug: FLUDARABINE;   Drug: CAMPATH 1H;   Drug: FK50;   Procedure: Stem Cell Collection and Infusion
7 Recruiting Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance
Condition: Precancerous/Nonmalignant Condition
Intervention: Biological: rituximab
8 Active, not recruiting Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous/Nonmalignant Condition
Interventions: Drug: celecoxib;   Other: placebo
9 Recruiting Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance
Conditions: Neuropathy;   Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
Intervention: Drug: Lenalidomide
10 Recruiting Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis
Conditions: Monoclonal Gammopathy;   Tuberculosis
Intervention:
11 Recruiting RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy
Condition: Polyneuropathy Associated With Anti-MAG IgM Gammopathy
Intervention: Drug: Rituximab
12 Completed Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Conditions: Breast Cancer;   Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders;   Leukemia;   Lung Cancer;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous/Nonmalignant Condition;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: epoetin alfa;   Procedure: quality-of-life assessment
13 Completed Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: fludarabine phosphate
14 Active, not recruiting Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: filgrastim;   Biological: therapeutic allogeneic lymphocytes;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Drug: melphalan;   Drug: methotrexate;   Drug: tacrolimus;   Procedure: peripheral blood stem cell transplantation
15 Completed Pyroxamide in Treating Patients With Advanced Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Precancerous/Nonmalignant Condition;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: pyroxamide
16 Recruiting Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Iodine I 131 Tositumomab
17 Not yet recruiting A Novel Vaccine for the Treatment of MUC1-Expressing Tumor Malignancies
Conditions: Multiple Myeloma;   Tumors
Intervention: Biological: Peptide Vaccine (MUC-1)
18 Active, not recruiting Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: lenalidomide;   Drug: dexamethasone
19 Active, not recruiting A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: dexamethasone;   Drug: Fludarabine;   Drug: Melphalan
20 Completed Safety and Anti-Disease Activity of CHR-2797 in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Multiple Myeloma
Intervention: Drug: Aminopeptidase inhibitor

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services